Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Darel Martínez Bedoya"'
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Outstanding results in hematological malignancies and encouraging pre-clinical anti-tumor activity against a wide
Externí odkaz:
https://doaj.org/article/451367ddc3494d2ab73eff4cfb3ff481
Autor:
Darel Martínez Bedoya
Publikováno v:
Revista Cubana de Investigaciones Biomédicas, Vol 31, Iss 4, Pp 417-428 (2012)
La liberación controlada de fármacos en el sitio del tumor y el desarrollo de técnicas no invasivas de monitoreo constituyen 2 de los principales retos que enfrentan las terapias antitumorales en la actualidad. En este trabajo se analizan algunas
Externí odkaz:
https://doaj.org/article/d716d670189b4cff9715015611b768d7
Autor:
Stoyan Tankov, Marija Petrovic, Marc Lecoultre, Felipe Espinoza, Nadia El-Harane, Viviane Bes, Sylvie Chliate, Darel Martinez Bedoya, Olivier Jordan, Gerrit Borchard, Denis Migliorini, Valérie Dutoit, Paul R. Walker
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-21 (2024)
Abstract Background Solid tumors such as glioblastoma (GBM) exhibit hypoxic zones that are associated with poor prognosis and immunosuppression through multiple cell intrinsic mechanisms. However, release of extracellular vesicles (EVs) has the poten
Externí odkaz:
https://doaj.org/article/1b626734d4794a029e5d6e64bca9f6ae
Autor:
Darel Martínez-Bedoya, Ana M Hernández-Vázquez, Teresa Rondón-Corrales, Tania Griñán-Ramirez, Nely Rodríguez-Zhurbenko, Amaury Pupo-Meriño, Lianet Cabrera-López, Judith Raymond-Pous, Ana M Vázquez-Gallo, Rolando Pérez-Rodríguez
Publikováno v:
Biotecnología Aplicada, Vol 35, Iss 2, Pp 2511-2513 (2018)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::7682f8aee2f252a336eddf64c20708bf
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522018000200006&tlng=en
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522018000200006&tlng=en
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2086
Chimeric antigen receptor (CAR) T cell therapies are ex vivo manufactured cellular products that have been useful in the treatment of blood cancers and solid tumors. The quality of the final cellular product is influenced by several amenable factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ffe1ade60d7126ce36ab6eccefe2722
https://pubmed.ncbi.nlm.nih.gov/31707678
https://pubmed.ncbi.nlm.nih.gov/31707678
Publikováno v:
Methods in Molecular Biology ISBN: 9781071601457
Chimeric antigen receptor (CAR) T cell therapies are ex vivo manufactured cellular products that have been useful in the treatment of blood cancers and solid tumors. The quality of the final cellular product is influenced by several amenable factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::325309cc011296b7e6ebb285151a1634
https://doi.org/10.1007/978-1-0716-0146-4_15
https://doi.org/10.1007/978-1-0716-0146-4_15
Autor:
Axel Mancebo Rodríguez, Ana M. Bada Barro, Darel Martínez Bedoya, Ángel Casacó Parada, Bárbara González Navarro, Arianna Iglesias Rivero, Avelina León Goñi, Consuelo González Triana, Meilis Mesa Angarica, Belinda Sánchez Ramírez
Publikováno v:
Vaccine. 31:89-95
Human epidermal growth factor receptor (HER1) constitutes a tumor associated antigen. Its overexpression in many epithelial tumors has been associated with bad prognosis and poor survival. Cancer vaccine based on the extracellular domain (ECD) of HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78667a27795bbeef511bd68c6f3caa20
https://doi.org/10.1016/j.vaccine.2012.10.098
https://doi.org/10.1016/j.vaccine.2012.10.098